Showing results (451-460 of 486) with videos related to
Sort By:
Pageof 49
Research and Practice in Thrombosis and Haemostasis|May 1, 2026
Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial resultsAndrew D Leavitt, Johnny Mahlangu, Priyanka Raheja, et al.Blood|June 23, 2017
Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleedingSarah K Westbury, Matthias Canault, Daniel Greene, et al.Research and Practice in Thrombosis and Haemostasis|December 17, 2024
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trialAndrew D Leavitt, Johnny Mahlangu, Priyanka Raheja, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2020
Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility StudyLisa Gallicchio, Joanne W Elena, Sarah Fagan, et al.Journal of Thrombosis and Haemostasis : JTH|April 13, 2024
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia ABella Madan, Margareth C Ozelo, Priyanka Raheja, et al.Pneumologie (Stuttgart, Germany)|September 2, 2021
[S1 Guideline Post-COVID/Long-COVID]Andreas Rembert Koczulla, Tobias Ankermann, Uta Behrends, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2019
Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell TransplantMaura Faraci, Tamara Diesch, Myriam Labopin, et al.Human Mutation|September 29, 2019
Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variantsLoredana Bury, Karyn Megy, Jonathan C Stephens, et al.Pneumologie (Stuttgart, Germany)|December 8, 2022
[German S1 Guideline Long-/Post-COVID]A R Koczulla, T Ankermann, U Behrends, et al.Allergologie Select|June 22, 2026
Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactationThomas Werfel, Annice Heratizadeh, Matthias Augustin, et al.Pageof 49